Characterization of a standardized glucagon challenge test as a pharmacodynamic tool in pharmacological research

Hormone and Metabolic Research

Volumn 46, Issue 4, 2014, Pages 269-273

  Van Dongen, M G J ^a   Geerts, B F ^b   Bhanot, S ^c   Morgan, E S ^c   De Kam, M L ^a   Moerland, M ^a   Romijn, J A ^d   Cohen, A F ^a   Burggraaf, J ^a  

^a CENTRE FOR HUMAN DRUG RESEARCH   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ISIS PHARMACEUTICALS   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

autonomic nervous system; diabetes mellitus type 2; glucagon; hepatic glucose production

Indexed keywords

BIOLOGICAL MARKER; GLUCAGON; GLUCAGON RECEPTOR; GLUCOSE; ISOTOPE; MESSENGER RNA; GLUCOSE BLOOD LEVEL;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BIOPSY; BODY FAT; CLAMP; DIABETES MELLITUS; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INFUSION; HEART RATE VARIABILITY; HUMAN; HUMAN TISSUE; HYPERGLUCAGONEMIA; HYPERGLYCEMIA; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROVOCATION TEST; REPRODUCIBILITY; ADOLESCENT; BLOOD; CLINICAL PHARMACOLOGY; CLINICAL TRIAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEART RATE; LIVER; METABOLISM; MIDDLE AGED; PROCEDURES; RESEARCH; STANDARD; STANDARDS; TIME; YOUNG ADULT;

ADIPOSE TISSUE; ADOLESCENT; ADULT; BLOOD GLUCOSE; FEMALE; GENE EXPRESSION REGULATION; GLUCAGON; HEART RATE; HUMANS; LIVER; MALE; MIDDLE AGED; PHARMACOLOGY, CLINICAL; RECEPTORS, GLUCAGON; REFERENCE STANDARDS; RESEARCH; RNA, MESSENGER; TIME FACTORS; YOUNG ADULT;

EID: 84899475851     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0033-1363223     Document Type: Article

References (25)

1. Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care: 2004; 27 1047 1053 (Pubitemid 38579764)
2. Lebovitz H. Diabetes: assessing the pipeline. Atheroscler Suppl: 2006; 7 43 49
3. 13C NMR. Science: 1991; 254 573 576 (Pubitemid 21917377)
4. Sloop K. W., Michael M. D., Moyers J. S. Glucagon as a target for the treatment of Type 2 diabetes. Expert Opin Ther Targets: 2005; 9 593 600 (Pubitemid 40883156)
5. Svoboda M., Tastenoy M., Vertongen P., Robberecht P. Relative quantitative analysis of glucagon receptor mRNA in rat tissues. Mol Cell Endocrinol: 1994; 105 131 137 (Pubitemid 24313980)
6. Edgerton D. S., Cherrington A. D. Glucagon as a critical factor in the pathology of diabetes. Diabetes: 2011; 60 377 380
7. Petersen K. F., Sullivan J. T. Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans. Diabetologia: 2001; 44 2018 2024 (Pubitemid 33124047)
8. Rivera N., Everett-Grueter C. A., Edgerton D. S., Rodewald T., Neal D. W., Nishimura E., Larsen M. O., Jacobsen L. O., Kristensen K., Brand C. L., Cherrington A. D. A novel glucagon receptor antagonist, NNC 25-0926, blunts hepatic glucose production in the conscious dog. J Pharmacol Exp Ther: 2007; 321 743 752 (Pubitemid 46624501)
9. Sorensen H., Brand C. L., Neschen S., Holst J. J., Fosgerau K., Nishimura E., Shulman G. I. Immunoneutralization of endogenous glucagon reduces hepatic glucose output and improves long term glycemic control in diabetic ob/ob mice. Diabetes: 2006; 55 2843 2848 (Pubitemid 44923685)
10. Lockton J. A., Poucher S. M. Single dose glucagon (0.5 mg IV bolus) administration in healthy human volunteers is a robust model for assessment of glycogenolysis: characterisation of the glucose excursion after glucagon challenge. J Pharmacol Toxicol Meth: 2007; 55 86 90 (Pubitemid 46048675)
11. Farah A., Tuttle R. Studies on the pharmacology of glucagon. J Pharmacol Exp Ther: 1960; 129 49 55
12. White C. M. A review of potential cardiovascular uses of intravenous glucagon administration. J Clin Pharmacol: 1999; 39 442 447 (Pubitemid 29356463)
13. Hansen L. H., Abrahamsen N., Nishimura E. Glucagon receptor mRNA distribution in rat tissues. Peptides: 1995; 16 1163 1166
14. Li Q. S., Liu X., van Doorn MB A., Kemme MJ B., van Hoogdalen E. J., Cohen A. F., Jones C. R., Ouwens M., Burggraaf J., de Kam M. L. Biopsy and RNA extraction procedures of muscle and adipose tissue for microarray gene-expression profiling. In: Biochips as pathways to drug discovery. Carmen A., Hardiman G. (eds.) Boca Raton, Florida CRC: 2006; 109 122
15. Heart rate variability Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J: 1996; 17 354 381
16. Reinauer H., Gries F. A., Hubinger A., Knode O., Severing K., Susanto F. Determination of glucose turnover and glucose oxidation rates in man with stable isotope tracers. J Clin Chem Clin Biochem: 1990; 28 505 511 (Pubitemid 20281863)
17. Liang Y., Osborne M. C., Monia B. P., Bhanot S., Gaarde W. A., Reed C., She P., Jetton T. L., Demarest K. T. Demarest KT. Reduction in glucagon receptor expression by an antisense oligonucleotide ameliorates diabetic syndrome in db/db mice. Diabetes: 2004; 53 410 417 (Pubitemid 38174557)
18. Rosenblatt J., Wolfe R. R. Calculation of substrate flux using stable isotopes. Am J Physiol: 1988; 254 E526 E531
19. Chernish S. M., Maglinte D. D. Glucagon: common untoward reactions-review and recommendations. Radiology: 1990; 177 145 146 (Pubitemid 20317337)
20. Matsuda M., DeFronzo R. A., Glass L., Consoli A., Giordano M., Bressler P., Delprato S. Glucagon dose-response curve for hepatic glucose production and glucose disposal in type 2 diabetic patients and normal individuals. Metabolism: 2002; 51 1111 1119
21. Magnusson I., Rothman D. L., Gerard D. P., Katz L. D., Shulman G. I. Contribution of hepatic glycogenolysis to glucose production in humans in response to a physiological increase in plasma glucagon concentration. Diabetes: 1995; 44 185 189
22. Ferrannini E., DeFronzo R. A., Sherwin R. S. Transient hepatic response to glucagon in man: role of insulin and hyperglycemia. Am J Physiol: 1982; 242 E73 E81 (Pubitemid 12099652)
23. Merlen C., Fabrega S., Desbuquois B., Unson C. G., Authier F. Glucagon-mediated internalization of serine-phosphorylated glucagon receptor and Gsalpha in rat liver. FEBS Lett: 2006; 580 5697 5704 (Pubitemid 44515091)
24. Cherrington A. D. Banting Lecture 1997. Control of glucose uptake and release by the liver in vivo. Diabetes: 1999; 48 1198 1214 (Pubitemid 29226371)
25. Thorens B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int J Obes (Lond): 2008; 32 06 S62 S71